Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: Association with early lymphatic spread of tumour cells
- 31 January 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (1) , 141-145
- https://doi.org/10.1016/0959-8049(95)00551-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: Frequency and prognostic significanceEuropean Journal Of Cancer, 1994
- Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumoursBritish Journal of Cancer, 1994
- Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrenceInternational Journal of Cancer, 1991
- Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysisInternational Journal of Cancer, 1990
- Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.Journal of Clinical Pathology, 1990
- The Melanoma Progression-Associated Antigen P3.58 is Identical to the Intercellular Adhesion Molecule, ICAM-1Immunobiology, 1988
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978